INTERNATIONAL PATENT: EUREKA THERAPEUTICS, INC., THE UNITED STATES GOVERNMENT, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES FILES APPLICATION FOR "CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF"

GENEVA, July 10 -- EUREKA THERAPEUTICS, INC. (5858 Horton Street, Suite 370Emeryville, California 94608), THE UNITED STATES GOVERNMENT, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Office of Technology Transfer, National Institutes of Health6701 Rockledge Drive, Suite 700, MSC 7788Bethesda, Maryland 20892-7788) filed a patent application (PCT/US2024/062156) for "CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF" on Dec 27, 2024. With publication no. WO/2025/145087, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property ...